Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions
Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-nephrology | Version: 2.0.0 | |||
Active as of 2024-11-26 | Computable Name: ReferralNephrology | |||
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.11.21 |
Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]
Generated Narrative: ActivityDefinition cc-cpg-activity-referral-nephrology
CQF Knowledge capability: shareable
CQF Knowledge capability: computable
CQF Knowledge capability: publishable
url: ActivityDefinition ReferralNephrology
identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.11.21
version: 2.0.0
name: ReferralNephrology
status: Active
experimental: true
date: 2024-11-26 06:42:34+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]
jurisdiction: World
relatedArtifact
type: Justification
display: Refer to nephrologist for co-management of treatment plan in cases of: Unclear etiology of kidney disease Rapid progression of disease (GFR decline greater than 5 mL/minute/1.73 m²/year) Acute kidney injury or abrupt sustained fall in GFR GFR less than 30 mL/minute/1.73 m² (GFR categories G4-G5) to prepare for renal replacement therapy Consistent finding of significant albuminuria (albumin/creatinine ratio of 300 mg/g or more) Hypertension resistant to treatment with 4 or more antihypertensive agents Difficulty in decreasing the level of albuminuria despite institution of ACE inhibitor or angiotensin II receptor blocker therapy Persistent electrolyte abnormalities, including hyperkalemia or high serum phosphate Recurrent or extensive nephrolithiasis Hereditary kidney disease Nephrologist involvement is recommended when the cause of chronic kidney disease is not clear Renal biopsy may be performed to determine the cause as well as to predict disease progression and response to therapy
citation:
Chronic Kidney Disease Clinical Overview. ClinicalKey. Source
Documents
Url http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325
kind: ServiceRequest
code: Referral to nephrologist
intent: Proposal
timing: Events: ??
Type |
Practitioner |